Format

Send to:

Choose Destination
See comment in PubMed Commons below
Lancet. 1997 Feb 8;349(9049):418-22.

Peptide antibiotics.

Author information

  • 1Department of Microbiology and immunology, University of British Columbia, Vancouver, Canada.

Abstract

The era of the "classical antibiotic" may be over. The emergence of resistance has seen to that. Yet no truly novel class of antibacterial agent has come on the market in the past 30 years. Currently there is great interest in peptide antibiotics, especially the cationic peptides. Thousands of such molecules have been synthesised and just a few are entering clinical trials. Because they kill bacteria quickly by the physical disruption of cell membranes, peptide antibiotics may not face the rapid emergence of resistance.

PMID:
9033483
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk